Literature DB >> 2217009

Acanthosis nigricans in obese women with the polycystic ovary syndrome: disease spectrum not distinct entity.

G S Conway1, H S Jacobs.   

Abstract

Fasting and stimulated insulin concentrations in four patients with acanthosis nigricans and polycystic ovary syndrome were compared with four patients, matched for weight and ovarian morphology, without acanthosis. The median fasting serum insulin concentrations were 114.2 and 25.1 mU/l in the respective groups (P = 0.02). One additional patient was investigated before and after an 18% increase in weight which resulted in a 170% increase in fasting insulin concentrations and the development of acanthosis nigricans. These observations suggest that there is variation between individuals in the degree of obesity that results in the development of acanthosis and that obese patients with this skin condition represent the severe end of the spectrum of the polycystic ovary syndrome.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2217009      PMCID: PMC2429633          DOI: 10.1136/pgmj.66.777.536

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  14 in total

Review 1.  Selective insulin action on skin, ovary, and heart in insulin-resistant states.

Authors:  M E Geffner; D W Golde
Journal:  Diabetes Care       Date:  1988-06       Impact factor: 19.112

2.  Metabolic importance of acanthosis nigricans.

Authors:  J S Flier
Journal:  Arch Dermatol       Date:  1985-02

3.  The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man.

Authors:  C R Kahn; J S Flier; R S Bar; J A Archer; P Gorden; M M Martin; J Roth
Journal:  N Engl J Med       Date:  1976-04-01       Impact factor: 91.245

4.  Acanthosis nigricans and obesity: acquired and intrinsic defects in insulin action.

Authors:  E J Peters; C A Stuart; M J Prince
Journal:  Metabolism       Date:  1986-09       Impact factor: 8.694

5.  Spectrum of endocrine abnormalities associated with acanthosis nigricans.

Authors:  L Y Matsuoka; J Wortsman; J R Gavin; J Goldman
Journal:  Am J Med       Date:  1987-10       Impact factor: 4.965

6.  Insulin resistance with acanthosis nigricans: the roles of obesity and androgen excess.

Authors:  C A Stuart; E J Peters; M J Prince; G Richards; A Cavallo; W J Meyer
Journal:  Metabolism       Date:  1986-03       Impact factor: 8.694

7.  Characterization of binding and phosphorylation defects of erythrocyte insulin receptors in the type A syndrome of insulin resistance.

Authors:  F Grigorescu; J S Flier; C R Kahn
Journal:  Diabetes       Date:  1986-02       Impact factor: 9.461

8.  Acanthosis nigricans, hirsutism, insulin resistance and insulin receptor defect.

Authors:  C E Leme; B L Wajchenberg; A C Lerário; J Goldman; J L Borges
Journal:  Clin Endocrinol (Oxf)       Date:  1982-07-01       Impact factor: 3.478

Review 9.  The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism.

Authors:  R L Barbieri; S Smith; K J Ryan
Journal:  Fertil Steril       Date:  1988-08       Impact factor: 7.329

10.  Acanthosis nigricans in obese women with hyperandrogenism. Characterization of an insulin-resistant state distinct from the type A and B syndromes.

Authors:  J S Flier; R C Eastman; K L Minaker; D Matteson; J W Rowe
Journal:  Diabetes       Date:  1985-02       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.